Drugs · acquisition-cost intelligence
Analpram HC
hydrocortisone acetate and pramoxine hydrochloride· ingredient pramoxineAnesthetics for topical use· HYDROCORTISONE ACETATE 10 mg/g; PRAMOXINE HYDROCHLORIDE 10 mg/g; HYDROCORTISONE ACETATE 1 g/100g; PRAMOXINE HYDROCHLORIDE 1 g/100g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$3.11
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 7 weeks.
2025-12-172026-05-27
Same-ingredient options by acquisition cost
Other pramoxine products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Calaclear | $0.01361 | −$3.10 |
| Bloop Hemorrhoid Relief Topical | $0.06318 | −$3.05 |
| antibiotic | $0.09664 | −$3.02 |
| hydrocortisone acetate pramoxine HCl | $1.75 | −$1.36 |
Medicare Part D coverage · CY2026
On 13 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.